OBJECTIVES: A previously unidentified mecA homologue, mecA(LGA251), has recently been described in methicillin-resistant Staphylococcus aureus (MRSA) from humans and dairy cattle. The origin and epidemiology of this novel homologue are unclear. The objective of this study was to provide basic descriptive information of MRSA isolates harbouring mecA(LGA251) from a range of host animal species. METHODS: A number of S. aureus isolates from historical animal isolate collections were chosen for investigation based on their similarity to known mecA(LGA251) MRSA isolates. The presence of mecA(LGA251) was determined using a multiplex PCR and antimicrobial susceptibility testing performed by disc diffusion. RESULTS: MRSA harbouring mecA(LGA251) were found in isolates from a domestic dog, brown rats, a rabbit, a common seal, sheep and a chaffinch. All of the isolates were phenotypically MRSA, although this depended on which test was used; some isolates would be considered susceptible with certain assays. All isolates were susceptible to linezolid, rifampicin, kanamycin, norfloxacin, erythromycin, clindamycin, fusidic acid, tetracycline, trimethoprim/sulfamethoxazole and mupirocin. Five multilocus sequence types were represented (2273, 130, 425, 1764 and 1245) and six spa types (t208, t6293, t742, t6594, t7914 and t843). CONCLUSIONS: The discovery of MRSA isolates possessing mecA(LGA251) from a diverse range of host species, including different taxonomic classes, has important implications for the diagnosis of MRSA in these species and our understanding of the epidemiology of this novel mecA homologue.
OBJECTIVES: A previously unidentified mecA homologue, mecA(LGA251), has recently been described in methicillin-resistant Staphylococcus aureus (MRSA) from humans and dairy cattle. The origin and epidemiology of this novel homologue are unclear. The objective of this study was to provide basic descriptive information of MRSA isolates harbouring mecA(LGA251) from a range of host animal species. METHODS: A number of S. aureus isolates from historical animal isolate collections were chosen for investigation based on their similarity to known mecA(LGA251) MRSA isolates. The presence of mecA(LGA251) was determined using a multiplex PCR and antimicrobial susceptibility testing performed by disc diffusion. RESULTS: MRSA harbouring mecA(LGA251) were found in isolates from a domestic dog, brown rats, a rabbit, a common seal, sheep and a chaffinch. All of the isolates were phenotypically MRSA, although this depended on which test was used; some isolates would be considered susceptible with certain assays. All isolates were susceptible to linezolid, rifampicin, kanamycin, norfloxacin, erythromycin, clindamycin, fusidic acid, tetracycline, trimethoprim/sulfamethoxazole and mupirocin. Five multilocus sequence types were represented (2273, 130, 425, 1764 and 1245) and six spa types (t208, t6293, t742, t6594, t7914 and t843). CONCLUSIONS: The discovery of MRSA isolates possessing mecA(LGA251) from a diverse range of host species, including different taxonomic classes, has important implications for the diagnosis of MRSA in these species and our understanding of the epidemiology of this novel mecA homologue.
Authors: Anna C Shore; Emily C Deasy; Peter Slickers; Grainne Brennan; Brian O'Connell; Stefan Monecke; Ralf Ehricht; David C Coleman Journal: Antimicrob Agents Chemother Date: 2011-06-02 Impact factor: 5.191
Authors: M Stegger; P S Andersen; A Kearns; B Pichon; M A Holmes; G Edwards; F Laurent; C Teale; R Skov; A R Larsen Journal: Clin Microbiol Infect Date: 2012-04 Impact factor: 8.067
Authors: Lance B Price; Marc Stegger; Henrik Hasman; Maliha Aziz; Jesper Larsen; Paal Skytt Andersen; Talima Pearson; Andrew E Waters; Jeffrey T Foster; James Schupp; John Gillece; Elizabeth Driebe; Cindy M Liu; Burkhard Springer; Irena Zdovc; Antonio Battisti; Alessia Franco; Jacek Zmudzki; Stefan Schwarz; Patrick Butaye; Eric Jouy; Constanca Pomba; M Concepción Porrero; Raymond Ruimy; Tara C Smith; D Ashley Robinson; J Scott Weese; Carmen Sofia Arriola; Fangyou Yu; Frederic Laurent; Paul Keim; Robert Skov; Frank M Aarestrup Journal: MBio Date: 2012-02-21 Impact factor: 7.867
Authors: Laura García-Álvarez; Matthew T G Holden; Heather Lindsay; Cerian R Webb; Derek F J Brown; Martin D Curran; Enid Walpole; Karen Brooks; Derek J Pickard; Christopher Teale; Julian Parkhill; Stephen D Bentley; Giles F Edwards; E Kirsty Girvan; Angela M Kearns; Bruno Pichon; Robert L R Hill; Anders Rhod Larsen; Robert L Skov; Sharon J Peacock; Duncan J Maskell; Mark A Holmes Journal: Lancet Infect Dis Date: 2011-08 Impact factor: 25.071
Authors: Roman Pantůček; Ivo Sedláček; Adéla Indráková; Veronika Vrbovská; Ivana Mašlaňová; Vojtěch Kovařovic; Pavel Švec; Stanislava Králová; Lucie Krištofová; Jana Kekláková; Petr Petráš; Jiří Doškař Journal: Appl Environ Microbiol Date: 2018-01-02 Impact factor: 4.792
Authors: K Saeed; N Ahmad; M Dryden; N Cortes; P Marsh; A Sitjar; S Wyllie; S Bourne; J Hemming; C Jeppesen; S Green Journal: Infection Date: 2014-06-12 Impact factor: 3.553
Authors: A C MacFadyen; E M Harrison; M J Ellington; J Parkhill; M A Holmes; G K Paterson Journal: J Antimicrob Chemother Date: 2018-12-01 Impact factor: 5.790
Authors: Ewan M Harrison; Gavin K Paterson; Matthew T G Holden; Fiona J E Morgan; Anders Rhod Larsen; Andreas Petersen; Sabine Leroy; Sarne De Vliegher; Vincent Perreten; Lawrence K Fox; Theo J G M Lam; Otlis C Sampimon; Ruth N Zadoks; Sharon J Peacock; Julian Parkhill; Mark A Holmes Journal: Antimicrob Agents Chemother Date: 2012-12-28 Impact factor: 5.191
Authors: A C MacFadyen; E M Harrison; I Drigo; J Parkhill; M A Holmes; G K Paterson Journal: J Antimicrob Chemother Date: 2019-03-01 Impact factor: 5.790
Authors: G K Paterson; J Larsen; E M Harrison; A R Larsen; F J Morgan; S J Peacock; J Parkhill; R N Zadoks; M A Holmes Journal: Euro Surveill Date: 2012-12-13
Authors: Ewan M Harrison; Gavin K Paterson; Matthew T G Holden; Jesper Larsen; Marc Stegger; Anders Rhod Larsen; Andreas Petersen; Robert L Skov; Judit Marta Christensen; Anne Bak Zeuthen; Ole Heltberg; Simon R Harris; Ruth N Zadoks; Julian Parkhill; Sharon J Peacock; Mark A Holmes Journal: EMBO Mol Med Date: 2013-03-25 Impact factor: 12.137